Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-16

Clinical Trial Update: Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study evaluating repeated, escalating intradermal doses of avotermin (Juvista) for wound healing and ci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix, Wound Healing | Phase 1 | Status: COMPLETED